These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 18160732)
1. Drug monitoring and toxicology (DMT). Neale S; Brown A; Jeffery J; Ayling RM Clin Chem; 2008 Jan; 54(1):218-20. PubMed ID: 18160732 [No Abstract] [Full Text] [Related]
2. Suspected drug reaction with piperacillin/tazobactam, in a premature infant. Maulidi H; Godambe S; Chow P Br J Clin Pharmacol; 2008 Jun; 65(6):971-2. PubMed ID: 18307542 [No Abstract] [Full Text] [Related]
3. Piperacillin-tazobactam-induced acute interstitial nephritis with possible meropenem cross-sensitivity in a patient with osteomyelitis. Liu TJ; Lam JP Am J Health Syst Pharm; 2012 Jul; 69(13):1109. PubMed ID: 22722588 [No Abstract] [Full Text] [Related]
4. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients? McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905 [TBL] [Abstract][Full Text] [Related]
5. Drug fever induced by piperacillin/tazobactam in an elderly patient with underlying human immunodeficiency virus (HIV) infection. Swe T; Ali M; Naing AT BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27440850 [TBL] [Abstract][Full Text] [Related]
16. Immune hemolysis due to piperacillin/tazobactam. Garcia Gala JM; Vazquez Aller S; Rodriguez Vicente P; Morante Pombo C Transfus Apher Sci; 2009 Apr; 40(2):97-8. PubMed ID: 19250872 [No Abstract] [Full Text] [Related]
17. A possible role of IL-23-producing cells in a patient with psoriasiform drug eruption due to tazobactam and piperacillin hydrate: a case study and literature review. Saito-Sasaki N; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Okada E; Nakamura M Eur J Dermatol; 2017 Feb; 27(1):88-89. PubMed ID: 27748262 [No Abstract] [Full Text] [Related]
18. Safety of Subcutaneous Piperacillin/Tazobactam Administration Compared to Intravenous Administration: Propensity Score-Matched Cohort Study. Kobayashi D; Cho M; Yokota K; Shimbo T J Am Med Dir Assoc; 2020 Jan; 21(1):127-128. PubMed ID: 31607553 [No Abstract] [Full Text] [Related]
19. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. Harris PNA; Tambyah PA; Lye DC; Mo Y; Lee TH; Yilmaz M; Alenazi TH; Arabi Y; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj S; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke D; Miyakis S; Walls G; Al Khamis M; Zikri A; Crowe A; Ingram P; Daneman N; Griffin P; Athan E; Lorenc P; Baker P; Roberts L; Beatson SA; Peleg AY; Harris-Brown T; Paterson DL; JAMA; 2018 Sep; 320(10):984-994. PubMed ID: 30208454 [TBL] [Abstract][Full Text] [Related]
20. Drug Fever Induced by Piperacillin/Tazobactam in a Scoliosis Patient: A Case Report. Li Z; Shen J; Li Q; Chan MTV; Wu WKK Medicine (Baltimore); 2015 Nov; 94(46):e1875. PubMed ID: 26579799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]